T. Rowe Price Investment Management
DXCM icon

T. Rowe Price Investment Management’s DexCom DXCM Stock Holding History

T. Rowe Price Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
35,418
+32,125
+976% +$2.14M ﹤0.01% 685
2026
Q1 		$207K Buy
3,293
+606
+23% +$42.2K ﹤0.01% 642
2025
Q4 		$179K Buy
2,687
+538
+25% +$34.8K ﹤0.01% 657
2025
Q3 		$145K Buy
2,149
+1,906
+784% +$151K ﹤0.01% 659
2025
Q2 		$22K Buy
+243
New +$19K ﹤0.01% 672

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management's DXCM Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its DexCom (DXCM) stake by 976% in Q2 2026, buying an estimated $2.14M and bringing the position to 35,418 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #685.

T. Rowe Price Investment Management first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • T. Rowe Price Investment Management held 35,418 shares of DexCom worth $2.39M as of Q2 2026.
  • T. Rowe Price Investment Management bought 32,125 DexCom shares in Q2 2026, an estimated $2.14M.
  • DexCom made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #685 holding.
  • T. Rowe Price Investment Management first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.